Media Contact: Susan Gregg - 206-390-3226, sghanson@uw.edu
UW Medicine Patient David Park rests after completing an infusion of donanemab at Harborview Medical Center.
UW Medicine patient David Park rests after completing his infusion of donanemab to treat Alzheimer's disease in April 2025 at Harborview Medical Center in Seattle. See associated news release.